 |
(S)-3-((S)-2-(2-((2,6-difluorophenyl)amino)-2-oxoacetamido)propanamido)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid |
|---|---|
| Trade Name | |
| Orphan Indication | Primary sclerosing cholangitis |
| EU Market Approval | EU |
| EU Designation Date | 2017-10-16 00:00:00 |
| Sponsor | Pharma Gateway AB |
